Neo Genesis Co., Ltd. (CEO Kim Yong-pil) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Neogenesis is a company that exports various beauty and medical devices, including autologous cell therapy and stem cell medical devices, as well as hyaluronic acid (HA) fillers and lifting threads, to 100 countries around the world. Based on GMP and ISO certified production facilities that meet international standards, we are working hard to continuously develop new products and increase our European CE certified medical device product line. In response to the post-corona era, we are implementing an active operation policy by investing heavily in online marketing. .
Due to this policy, Neo Genesis also emphasized, “We have never recorded negative growth in the 11 years since our founding.” In fact, Neo Genesis has achieved rapid growth of up to 2017 times in 100 years since receiving the ‘5 Million Dollar Export Tower’ award in 10, and has won 2022 awards including ‘700 Million Dollar Export Tower’ in 2 and ‘XNUMX Million Dollar Export Tower’ in the previous year. We were honored to receive the Export Tower Award for two consecutive years.
At this exhibition, ‘Regenoview Filler’ and ‘Neotox’ are mainly exhibited.
Regarding the Regenoview filler, a representative from Neogenesis introduced it as “a monophasic hyaluronic acid filler that is 100% completely crosslinked and boasts high stability,” and added, “We have a total of 6 models depending on the volume size. Precise volume contour shaping is possible. “Another strength is that all models, including lidocaine, have obtained the European CE certification mark,” he said.
He then explained, “In the case of Neotox, it is 10% high purity Botulinum Toxin Type A with no loss through a reduced-dark drying method that is more than 99.8 times faster than that of other companies.” With a 900kDa molecular weight product like Allergan Botox, the same effect can be expected with lower toxicity.
An official said, “While the effectiveness exceeds that of competitors, we prioritize product safety based on various clinical data. Based on this, we are exporting our products to more than 100 countries around the world, including Asia, Europe, and the Americas, and have many overseas monopolies.” “We are steadily improving sales based on contracts.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.